HCN4 Antibodies

Santa Cruz Biotechnology offers a broad range of HCN4 monoclonal antibodies for research focused on understanding HCN4 protein function. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HCN4, or hyperpolarization-activated cyclic nucleotide-gated channel 4, is crucial for regulating cardiac pacemaker activity and neuronal excitability. HCN4 plays a significant role in controlling heart rate and rhythm, making it an essential target for studies related to cardiac function and arrhythmias. Research involving HCN4 can provide insights into various cardiovascular diseases and potential therapeutic approaches. Investigating HCN4 expression and function helps advance understanding of cardiac rhythm disorders and their treatments. Studying HCN4 channels contributes to developing new therapeutic strategies for cardiac arrhythmias. Exploring HCN4's role in neuronal function provides valuable insights into nervous system regulation. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cardiovascular and neurological health.